Glenmark Pharmaceuticals Ltd. Reaches All-Time High Price, Reflecting Strong Market Performance
Glenmark Pharmaceuticals Ltd. has achieved an all-time high price of Rs.1800 on October 10th, 2024, showcasing its strong performance in the market. The stock has outperformed the Sensex with a 1-year performance of 126.56%. Despite some volatility, the stock remains above its moving averages, indicating a positive trend.
Glenmark Pharmaceuticals Ltd., a largecap pharmaceutical company, has reached an all-time high price of Rs.1800 on October 10th, 2024. This news comes as the stock has been performing well in the market, with a 1-year performance of 126.56% compared to the Sensex's 23.55% performance.
According to MarketsMOJO, a leading stock analysis and recommendation platform, the current call for Glenmark Pharmaceuticals Ltd. is 'Hold'. The stock has also underperformed the sector by -0.49% today, after a 4-day consecutive gain.
The stock has been trading in a narrow range of Rs.13 and has shown high volatility with an intraday volatility of 269.57% (calculated from weighted average price). However, Glenmark Pharma is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.
Glenmark Pharmaceuticals Ltd. is a leading player in the pharmaceutical industry, with a large market cap. Its recent all-time high price is a testament to its strong performance and growth in the market. This news is sure to be welcomed by investors and stakeholders of the company.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Activity
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
Most Read
